(Q38154412)

29 August 2017

Research advances in basic mechanisms of seizures and antiepileptic drug action (English)

1 reference

29 August 2017

1

Władysław Lasoń

1 reference

29 August 2017

3

Konrad Rejdak

1 reference

29 August 2017

Małgorzata Chlebicka

2

1 reference

PubMed ID

24145073

29 August 2017

language of work or name

1 reference

1 January 2013

1 reference

29 August 2017

Pharmacological Reports

1 reference

29 August 2017

65

1 reference

29 August 2017

4

1 reference

29 August 2017

787-801

1 reference

Metabotropic glutamate receptors as a strategic target for the treatment of epilepsy

29 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Network and pharmacological mechanisms leading to epileptiform synchronization in the limbic system in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

GABAergic synchronization in the limbic system and its role in the generation of epileptiform activity.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Genesis of epileptic interictal spikes. New knowledge of cortical feedback systems suggests a neurophysiological explanation of brief paroxysms

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Production of seizures and brain damage in rats by alpha-dendrotoxin, a selective K+ channel blocker.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Block of (Na+,K+)ATPase with ouabain induces spreading depression-like depolarization in hippocampal slices.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Review of therapeutic options for adjuvant treatment of focal seizures in epilepsy: focus on lacosamide.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Seizures beget seizures: the quest for GABA as a key player

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Chemical properties of antiepileptic drugs (AEDs).

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

A potassium channel mutation in neonatal human epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Retigabine: chemical synthesis to clinical application.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Hippocampal kainate receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Adenosine dysfunction in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

2-Methyl-6-phenylethynyl-pyridine (MPEP), a non-competitive mGluR5 antagonist, differentially affects the anticonvulsant activity of four conventional antiepileptic drugs against amygdala-kindled seizures in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Seizures and reduced life span in mice lacking the potassium channel subunit Kv1.2, but hypoexcitability and enlarged Kv1 currents in auditory neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Extrasynaptic GABA(A) receptors: their function in the CNS and implications for disease

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Selective changes in single cell GABA(A) receptor subunit expression and function in temporal lobe epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Muscarinic suppression of a novel voltage-sensitive K+ current in a vertebrate neurone

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Neural KCNQ (Kv7) channels

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Effects of neurosteroids on spike-wave discharges in the genetic epileptic WAG/Rij rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Astrocyte calcium signaling and epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Pharmacology and functions of metabotropic glutamate receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Potassium channels: how genetic studies of epileptic syndromes open paths to new therapeutic targets and drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Enhanced tonic GABAA inhibition in typical absence epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Recent advances in the modulation of voltage-gated ion channels for the treatment of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

The new generation of GABA enhancers. Potential in the treatment of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

NKCC1 transporter facilitates seizures in the developing brain

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Do glia have heart? Expression and functional role for ether-a-go-go currents in hippocampal astrocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Three mechanisms underlie KCNQ2/3 heteromeric potassium M-channel potentiation.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Novel medications for epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

The NMDA receptor may participate in widespread suppression of circuit level neural activity, in addition to a similarly prominent role in circuit level activation

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Novel KCNQ2/Q3 agonists as potential therapeutics for epilepsy and neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Isoform-specific prolongation of Kv7 (KCNQ) potassium channel opening mediated by new molecular determinants for drug-channel interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Pharmacological modulation of GABA(B) receptors affects cocaine-induced seizures in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

The NMDA receptor complex as a therapeutic target in epilepsy: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Muscarinic acetylcholine receptor-mediated effects in slices from human epileptogenic cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Neocortical microenvironment in patients with intractable epilepsy: potassium and chloride concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Alterations in the microenvironment during spreading depression associated with epileptiform activity in the immature neocortex

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Extracellular chloride and the maintenance of spontaneous epileptiform activity in rat hippocampal slices.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Perturbed chloride homeostasis and GABAergic signaling in human temporal lobe epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Adenosine release during seizures attenuates GABAA receptor-mediated depolarization.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Reduction of K+ uptake in glia prevents long-term depression maintenance and causes epileptiform activity.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Neuronal KCNQ potassium channels: physiology and role in disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Identification of a possible pathogenic link between congenital long QT syndrome and epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Roles of group II metabotropic glutamate receptors in modulation of seizure activity.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

The roles of GABAB receptors in cortical network activity.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Voltage-gated sodium channels in epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Dysfunction of GABAA receptor glycolysis-dependent modulation in human partial epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Basic mechanisms of antiepileptic drugs and their pharmacokinetic/pharmacodynamic interactions: an update

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Gene expression in temporal lobe epilepsy is consistent with increased release of glutamate by astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Functional roles of synaptic and extrasynaptic NMDA receptors in physiological and pathological neuronal activities.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Adenosine dysfunction in astrogliosis: cause for seizure generation?

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

The role of astroglia in the epileptic brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Selective alterations in GABAA receptor subtypes in human temporal lobe epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Disruption of Kv1.1 N-type inactivation by novel small molecule inhibitors (disinactivators).

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Activation of pre-synaptic M-type K+ channels inhibits [3H]D-aspartate release by reducing Ca2+ entry through P/Q-type voltage-gated Ca2+ channels.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Extracellular proteases in epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Third-generation antiepileptic drugs: mechanisms of action, pharmacokinetics and interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Dynorphin selectively augments the M-current in hippocampal CA1 neurons by an opiate receptor mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Neuronal and non-neuronal GABA transporters as targets for antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

1 reference

7 January 2021

Metabotropic glutamate receptors as a target for anticonvulsant and anxiolytic action in immature rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

1 reference

7 January 2021

Gabapentin-mediated inhibition of voltage-activated Ca2+ channel currents in cultured sensory neurones is dependent on culture conditions and channel subunit expression.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Anticonvulsant effects of four neuropeptides in the rat hippocampus during self-sustaining status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

On the cellular and network bases of epileptic seizures.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Molecular targets for antiepileptic drug development

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Molecular pharmacology and therapeutic potential of neuronal Kv7-modulating drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Gating currents from Kv7 channels carrying neuronal hyperexcitability mutations in the voltage-sensing domain.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Low extracellular magnesium induces epileptiform activity and spreading depression in rat hippocampal slices

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Glutamate metabotropic receptors as targets for drug therapy in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Valproate causes reduction of the excitatory amino acid aspartate in nerve terminals.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

New antiepileptic drugs: molecular targets

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Risk factors in sudden death in epilepsy (SUDEP): the quest for mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Metabotropic glutamate receptors in the thalamocortical network: strategic targets for the treatment of absence epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Future prospects for the drug treatment of epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Congenital long QT syndrome presenting with a history of epilepsy: misdiagnosis or relationship between channelopathies of the heart and brain?

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

A spontaneous mutation involving Kcnq2 (Kv7.2) reduces M-current density and spike frequency adaptation in mouse CA1 neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Molecular basis of NMDA receptor functional diversity.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Electrophysiology and beyond: multiple roles of Na+ channel β subunits in development and disease

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Progressive loss of phasic, but not tonic, GABAA receptor-mediated inhibition in dentate granule cells in a model of post-traumatic epilepsy in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Tonic GABA(A) receptor-mediated signalling in temporal lobe epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Epileptiform activity induced by pharmacologic reduction of M-current in the developing hippocampus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Changes in KCNQ2 immunoreactivity in the amygdala in two rat models of temporal lobe epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Exploring HCN channels as novel drug targets

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

K+ M-current regulates the transition to seizures in immature and adult hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Somatostatin receptor subtype 4 couples to the M-current to regulate seizures.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Developmental seizure susceptibility of kv1.1 potassium channel knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Mechanisms of seizure-induced 'transcriptional channelopathy' of hyperpolarization-activated cyclic nucleotide gated (HCN) channels

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

The K+/Cl- co-transporter KCC2 renders GABA hyperpolarizing during neuronal maturation

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Kv1.1 and Kv1.2: similar channels, different seizure models

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

In vivo profile of ICA-27243 [N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide], a potent and selective KCNQ2/Q3 (Kv7.2/Kv7.3) activator in rodent anticonvulsant models

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Revisiting AMPA receptors as an antiepileptic drug target

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

New molecular targets for antiepileptic drugs: alpha(2)delta, SV2A, and K(v)7/KCNQ/M potassium channels

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

The neurobiology of antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Voltage-gated sodium channels: biophysics, pharmacology, and related channelopathies.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

GABA transport inhibitors and seizure protection: the past and future

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

KCNQ5, a novel potassium channel broadly expressed in brain, mediates M-type currents

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Somatostatin increases a voltage-insensitive K+ conductance in rat CA1 hippocampal neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Increased NKCC1 expression in refractory human epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

HCN and KV7 (M-) channels as targets for epilepsy treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions show seizures and neuronal plasticity without synaptic reorganization.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Chromosomal abnormalities and epilepsy: a review for clinicians and gene hunters

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Deletion of the K(V)1.1 potassium channel causes epilepsy in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Potassium-induced enhancement of persistent inward current in hippocampal neurons in isolation and in tissue slices

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Pharmacotherapy of epilepsy: newly approved and developmental agents

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

GABAergic mechanisms in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Review: cholinergic mechanisms and epileptogenesis. The seizures induced by pilocarpine: a novel experimental model of intractable epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Collapse of extracellular glutamate regulation during epileptogenesis: down-regulation and functional failure of glutamate transporter function in rats with chronic seizures induced by kainic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Opposite effects of T- and L-type Ca(2+) channels blockers in generalized absence epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Therapeutic potential of new antiinflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Kainate receptors in epilepsy and excitotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Regulation of excitability by extrasynaptic GABA(A) receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

A family of potassium channel genes related to eag in Drosophila and mammals

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Classical neurotransmitters and neuropeptides involved in generalized epilepsy: a focus on antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Potassium channels as anti-epileptic drug targets

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Important role of matrix metalloproteinase 9 in epileptogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Anti-convulsant and adverse effects of the glycineB receptor ligands, D-cycloserine and L-701,324: comparison with competitive and non-competitive N-methyl-D-aspartate receptor antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Differential effects of glycine on the anticonvulsant activity of D-cycloserine and L-701,324 in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

The new anticonvulsant retigabine favors voltage-dependent opening of the Kv7.2 (KCNQ2) channel by binding to its activation gate

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Acid-sensing ion channels (ASICs) as pharmacological targets for neurodegenerative diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Matrix metalloproteinase-9 may be a potential therapeutic target in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

Altered localization of GABA(A) receptor subunits on dentate granule cell dendrites influences tonic and phasic inhibition in a mouse model of epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971060-0

7 January 2021

10.1016/S1734-1140(13)71060-0

Identifiers

DOI

1 reference

release_6m2ioqadwvaizgdbzy2oa43isa

29 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6m2ioqadwvaizgdbzy2oa43isa

24 November 2022

mapped directly with Wikidata item

PubMed ID

24145073

1 reference

PubMed ID

24145073